Standards for nanomaterials and cardiac valve prostheses make the grade in US
This article was originally published in SRA
The US Food and Drug Administration has made 20 new entries to its list of recognized medical device standards for use in pre-market reviews1. Other changes to the list include the withdrawal of standards and their replacement by others where applicable, correction of errors in previously recognized standards, and changes to the supplementary information sheets of recognized standards that describe revisions to the applicability of the standards.
You may also be interested in...
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.